Skip to main content

Peer Review reports

From: DCLRE1B promotes tumor progression and predicts immunotherapy response through METTL3-mediated m6A modification in pancreatic cancer

Original Submission
29 Aug 2023 Submitted Original manuscript
4 Oct 2023 Reviewed Reviewer Report
13 Oct 2023 Reviewed Reviewer Report - Ramakrishna Vadde
Resubmission - Version 2
Submitted Manuscript version 2
Publishing
13 Oct 2023 Editorially accepted
7 Nov 2023 Article published 10.1186/s12885-023-11524-8

You can find further information about peer review here.

Back to article page